Index NDX, S&P 500
P/E 41.10
EPS (ttm) 13.57
Insider Own 0.38%
Shs Outstand 106.90M
Perf Week -1.14%
Market Cap 59.82B
Forward P/E 27.92
EPS next Y 19.98
Insider Trans -8.76%
Shs Float 106.82M
Perf Month 2.80%
Income 1.46B
PEG 4.11
EPS next Q 4.73
Inst Own 94.10%
Short Float 1.03%
Perf Quarter 1.85%
Sales 6.78B
P/S 8.83
EPS this Y 9.15%
Inst Trans -0.66%
Short Ratio 2.42
Perf Half Y 1.37%
Book/sh 173.20
P/B 3.22
EPS next Y 9.55%
ROA 4.90%
Short Interest 1.10M
Perf Year 4.18%
Cash/sh 2.51
P/C 221.90
EPS next 5Y 10.00%
ROE 8.24%
52W Range 508.22 - 580.09
Perf YTD 2.34%
Dividend Est. 2.75 (0.49%)
P/FCF 26.91
EPS past 5Y 7.03%
ROI 5.59%
52W High -3.82%
Beta 1.03
Dividend TTM 3.00 (0.54%)
Quick Ratio 0.44
Sales past 5Y 3.91%
Gross Margin 69.68%
52W Low 9.78%
ATR (14) 10.30
Dividend Ex-Date Jan 03, 2025
Current Ratio 0.48
EPS Y/Y TTM 14.98%
Oper. Margin 28.56%
RSI (14) 49.09
Volatility 2.02% 1.83%
Employees 16800
Debt/Eq 0.45
Sales Y/Y TTM 13.02%
Profit Margin 21.61%
Recom 2.32
Target Price 610.83
Option/Short Yes / Yes
LT Debt/Eq 0.41
EPS Q/Q 6.86%
Payout 22.02%
Rel Volume 1.65
Prev Close 575.95
Sales Surprise 2.37%
EPS Surprise 1.98%
Sales Q/Q 12.87%
Earnings Oct 23 BMO
Avg Volume 456.04K
Price 557.90
SMA20 -0.69%
SMA50 0.68%
SMA200 1.90%
Trades
Volume 750,838
Change -3.13%
Date
Action
Analyst
Rating Change
Price Target Change
Today Downgrade
Barclays
Overweight → Underweight
$625 → $569
Jul-25-24 Upgrade
Robert W. Baird
Neutral → Outperform
$617 → $635
Jun-13-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Mar-22-24 Reiterated
Oppenheimer
Outperform
$580 → $650
Jan-04-24 Downgrade
TD Cowen
Outperform → Market Perform
$535
Jul-24-23 Resumed
Wolfe Research
Outperform
$558
Jun-27-23 Initiated
Jefferies
Buy
$530
May-02-23 Upgrade
Bernstein
Underperform → Mkt Perform
$490 → $525
Mar-23-23 Initiated
Mizuho
Neutral
$475
Mar-22-23 Upgrade
JP Morgan
Underweight → Neutral
$385 → $420
Mar-20-23 Initiated
Truist
Buy
$510
Feb-23-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$480
Aug-17-22 Initiated
Bernstein
Mkt Perform
$505 → $490
Jan-11-22 Initiated
Bernstein
Mkt Perform
$505
Dec-17-21 Initiated
Mizuho
Buy
$550
Dec-15-21 Initiated
Wolfe Research
Peer Perform
$487
Oct-04-21 Upgrade
Raymond James
Outperform → Strong Buy
$550
Jun-30-21 Reiterated
Oppenheimer
Outperform
$505 → $560
Mar-18-21 Upgrade
Barclays
Equal Weight → Overweight
$410 → $440
Mar-17-21 Upgrade
Oppenheimer
Perform → Outperform
$460
Show Previous Ratings
Nov-28-24 11:32AM
Nov-26-24 08:30AM
Nov-19-24 10:03AM
09:00AM
Nov-06-24 01:00PM
01:04AM
Loading…
Nov-02-24 01:04AM
Oct-30-24 10:03AM
Oct-29-24 10:18AM
10:00AM
Oct-28-24 11:00AM
Oct-25-24 09:20AM
Oct-24-24 03:04AM
02:00AM
(Thomson Reuters StreetEvents)
Oct-23-24 03:43PM
09:30AM
09:00AM
Loading…
09:00AM
09:00AM
08:06AM
08:05AM
07:03AM
(Associated Press Finance)
06:55AM
Oct-18-24 09:15AM
Oct-16-24 09:04AM
Oct-15-24 11:26AM
Oct-09-24 04:36PM
Oct-04-24 09:00AM
07:00AM
(Investor's Business Daily)
Oct-02-24 05:00AM
Sep-18-24 01:58PM
12:00PM
10:03AM
Loading…
Sep-16-24 10:03AM
Sep-04-24 09:00AM
Sep-03-24 08:50AM
Aug-27-24 10:29AM
09:00AM
Aug-23-24 11:31AM
09:00AM
Aug-22-24 12:00PM
10:01AM
Aug-21-24 10:12AM
Aug-19-24 07:00PM
07:54AM
Aug-16-24 02:09PM
Aug-15-24 08:37AM
08:30AM
08:30AM
Jul-30-24 09:00AM
Jul-26-24 05:44PM
Jul-24-24 10:51PM
(Thomson Reuters StreetEvents) -7.37%
04:37PM
02:04PM
10:19AM
09:30AM
08:05AM
07:02AM
(Associated Press Finance)
06:55AM
Jul-19-24 11:45AM
Jul-17-24 10:01AM
09:04AM
Jul-12-24 09:45AM
Jul-11-24 10:00AM
Jul-04-24 06:00PM
03:54PM
Jul-03-24 08:56AM
Jul-02-24 08:30AM
Jun-28-24 07:30AM
Jun-20-24 04:22PM
03:15PM
Jun-18-24 02:08PM
01:18PM
09:00AM
Jun-12-24 12:30PM
Jun-10-24 01:57PM
Jun-04-24 02:59PM
May-28-24 12:43PM
May-22-24 08:30AM
May-21-24 12:45PM
10:00AM
May-20-24 07:04PM
May-16-24 06:45AM
May-09-24 09:26AM
09:00AM
May-04-24 07:38AM
May-03-24 06:00AM
May-02-24 12:00PM
May-01-24 12:51PM
09:55AM
Apr-30-24 09:35AM
Apr-29-24 07:15PM
10:39AM
09:07AM
07:40AM
06:39AM
Apr-28-24 08:20PM
Apr-27-24 03:01AM
12:01AM
(Thomson Reuters StreetEvents)
Apr-26-24 12:33PM
12:26PM
11:58AM
11:54AM
Roper Technologies, Inc. is a diversified technology company, which engages in the provision of engineered products and solutions for global niche markets. It operates through the following segments: Application Software, Network Software, and Technology Enabled Products. The Application Software segment includes Aderant, CBORD/Horizon, CliniSys, Data Innovations, Deltek, Frontline Education, IntelliTrans, PowerPlan, Strata, and Vertafore. The Network Software segment is composed of ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment refers to CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. The company was founded by George D. Roper in 1890 and is headquartered in Sarasota, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
JOHNSON ROBERT D Director Dec 03 '24 Sale 561.80 940 528,092 4,219 Dec 04 04:30 PM SABRINA & ROBERT TRUST Director Dec 03 '24 Proposed Sale 561.80 940 528,089 Dec 03 04:23 PM HUNN LAURENCE NEIL President and CEO Nov 08 '24 Option Exercise 156.40 30,000 4,692,000 117,311 Nov 12 04:12 PM HUNN LAURENCE NEIL President and CEO Nov 08 '24 Sale 572.47 30,000 17,174,101 87,311 Nov 12 04:12 PM WRIGHT CHRISTOPHER Director Nov 08 '24 Sale 568.82 681 387,366 34,869 Nov 12 04:12 PM WRIGHT CHRISTOPHER Director Nov 08 '24 Proposed Sale 568.82 681 387,366 Nov 12 12:42 PM HUNN LAURENCE NEIL Officer Nov 08 '24 Proposed Sale 572.47 30,000 17,174,091 Nov 08 01:52 PM WALLMAN RICHARD F Director Oct 24 '24 Sale 550.00 1,000 550,000 0 Oct 28 04:06 PM WALLMAN RICHARD F Director Oct 24 '24 Sale 550.00 1,000 550,000 32,955 Oct 28 04:06 PM WALLMAN RICHARD F Director Oct 25 '24 Sale 547.00 417 228,099 32,538 Oct 28 04:06 PM WALLMAN RICHARD F Director Oct 28 '24 Proposed Sale 544.00 2,000 1,088,000 Oct 28 04:04 PM WALLMAN RICHARD F Director Oct 25 '24 Proposed Sale 547.00 417 228,099 Oct 25 04:25 PM WALLMAN RICHARD F Director Oct 24 '24 Proposed Sale 550.00 2,000 1,100,000 Oct 24 04:25 PM JOHNSON ROBERT D Director Sep 13 '24 Sale 553.78 750 415,335 5,159 Sep 17 04:09 PM SABRINA & ROBERT TRUST Officer Sep 13 '24 Proposed Sale 553.78 750 415,338 Sep 13 05:25 PM JOHNSON ROBERT D Director Jul 26 '24 Sale 550.34 140 77,048 5,909 Jul 29 04:05 PM SABRINA & ROBERT TRUST U/T/A D Officer Jul 26 '24 Proposed Sale 550.34 140 77,047 Jul 26 04:37 PM Conley Jason EVP, Chief Financial Officer Jun 20 '24 Sale 563.02 3,500 1,970,555 33,685 Jun 21 04:30 PM WRIGHT CHRISTOPHER Director Jun 18 '24 Sale 551.74 400 220,696 35,550 Jun 20 04:15 PM WRIGHT CHRISTOPHER Director Jun 07 '24 Sale 554.67 300 166,401 35,247 Jun 10 04:50 PM WRIGHT CHRISTOPHER Director Mar 18 '24 Sale 549.71 200 109,941 35,547 Mar 19 04:02 PM WRIGHT CHRISTOPHER Director Feb 16 '24 Sale 547.00 300 164,100 35,747 Feb 20 04:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite